Besides the failure to control the AD progression in this P301S mouse model, these results open the path to generate novel optimized tau immunogens able to induce a better tau antigen presentation to the immune system and to develop novel vaccination protocols that could control disease progression. This evidence concerns the gene MAPT and Alzheimer disease.